The Drug Enforcement Agency (DEA) and the U.S. Department of Health and Human Services (HHS) have announced a temporary extension of telemedicine flexibilities under the Ryan Haight Act, allowing clinicians to continue prescribing controlled substances via telemedicine without an initial in-person visit. The temporary extension is through December 31, 2026.
This temporary extension can help ensure continuity of care and prevent disruptions of care amongst seniors, rural residents, and those receiving treatment for mental health conditions while federal agencies finalize permanent telemedicine regulations.
For more information and official guidance, visit: https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Andie Tena is Assistant Vice President, Practice Management Services. Questions or comments related to this column should be directed to ATena@CAPphysicians.com.